DRKS00004877已完成不适用
Resistant MS Spasticity Treatment with Sativex and Driving
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 33
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •*= 18 years old
- •*MS patients with moderate to severe spasticity due to multiple sclerosis (MS) who have not responded adequately to other anti-spasticity medication.
- •*Medical decision made to start Sativex® at the time of enrolment in the study
- •*Driving at present (at least once a week)
- •*Indication for Sativex® in accordance with the SPC (add-on to existing antispasticity medication and all SPC requirements
- •*Consent form signed by the patient
排除标准
- •*Spasticity due to causes other than multiple sclerosis
- •*Patients with severe cardio-vascular diseases
- •*Pregnant woman or woman in the breast-feeding period
- •*Reformed alcoholics
- •*Patients with relevant cognitive impairment or shortcomings in their knowledge of national language to suggest that that the logics and the rules of the driving ability tests are not fully understood and/or the patient questionnaires cannot be completed
研究者
相似试验
已完成
不适用
The Role of SAtivex® in Robotic-RehabilitationRehabilitationNCT03186664IRCCS Centro Neurolesi "Bonino-Pulejo"40
进行中（未招募）
不适用
Effect of Sativex on pain and spasticity following spinal cord injuryEUCTR2012-005328-14-DKSpinal Cord Injury Centre of Western Denmark
已完成
3 期
A Study to Evaluate the Efficacy of Sativex in Relieving Symptoms of Spasticity Due to Multiple SclerosisMultiple SclerosisNCT01599234Jazz Pharmaceuticals337
已完成
3 期
A Study of Sativex in the Treatment of Central Neuropathic Pain Due to Multiple SclerosisNeuropathic PainMultiple SclerosisNCT01604265Jazz Pharmaceuticals66
已完成
不适用
ong-term management of spasticity in patients with multiple sclerosis using a software application (APP) based hometraining: a prospective, randomized-controlled multicenter studyG35Multiple sclerosisDRKS00023960Reha Zentrum Münster94